Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell therapy for left ventricular remodeling.

Doris A Taylor1, Andrey G Zenovich

  • 1Department of Integrative Biology/Physiology, University of Minnesota, 312 Church Street SE, 7-105A Nils Hasselmo Hall, Minneapolis, MN 55455, USA. dataylor@umn.edu

Current Heart Failure Reports
|March 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation.

Respiratory research·2022
Same author

Analysis of sex-based differences in clinical and molecular responses to ischemia reperfusion after lung transplantation.

Respiratory research·2021
Same author

Restoring anatomical complexity of a left ventricle wall as a step toward bioengineering a human heart with human induced pluripotent stem cell-derived cardiac cells.

Acta biomaterialia·2021
Same author

Construction and Evaluation of a Bio-Engineered Pump to Enable Subpulmonary Support of the Fontan Circulation: A Proof-of-Concept Study.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2021
Same author

Peripheral Blood Biomarkers Associated With Improved Functional Outcome in Patients With Chronic Left Ventricular Dysfunction: A Biorepository Evaluation of the FOCUS-CCTRN Trial.

Frontiers in cardiovascular medicine·2021
Same author

Engineering Functional Vasculature in Decellularized Lungs Depends on Comprehensive Endothelial Cell Tropism.

Frontiers in bioengineering and biotechnology·2021
Same journal

From Cardioprotection to Trial Design: Rethinking Cardiac Safety in Oncology.

Current heart failure reports·2026
Same journal

Acute and Chronic Myocarditis in Men and Women.

Current heart failure reports·2026
Same journal

Smart Technology, Fragile Hearts: Navigating AI's Challenges and Limitations in Heart Failure Management.

Current heart failure reports·2026
Same journal

Palliative Care in Advanced Heart Failure.

Current heart failure reports·2026
Same journal

The Evolving Utility of Artificial Intelligence-Based Tools for the Detection of Heart Failure and Cardiomyopathies: From Potential to Implementation.

Current heart failure reports·2026
Same journal

Emerging Artificial Intelligence Tools for the Screening of Structural and Valvular Heart Disease.

Current heart failure reports·2026
See all related articles

Cell transplantation shows promise for heart failure (HF) patients, but varied study designs hinder progress. Standardized trials and data registries are crucial for advancing cell-based therapies to improve quality of life.

Area of Science:

  • Cardiology and Regenerative Medicine
  • Investigating novel cell-based therapies for cardiovascular diseases

Background:

  • Rising heart failure (HF) incidence and patient longevity necessitate improved treatments for left ventricular remodeling.
  • Previous cell transplantation studies (skeletal myoblasts, bone marrow mononuclear cells) in over 200 HF patients yielded mixed results.

Purpose of the Study:

  • To address the need for standardized approaches in cell-based therapies for heart failure.
  • To improve the efficacy and safety of cell transplantation for treating left ventricular remodeling.

Main Methods:

  • Review of existing safety/feasibility studies of cell transplantation in heart failure patients.
  • Identification of critical factors hindering comparative analysis: patient populations, cell types, dosing, timing, delivery methods, and outcome measures.

Related Experiment Videos

Main Results:

  • Early studies demonstrated potential symptomatic and functional improvements but also raised safety concerns.
  • Significant heterogeneity across trials makes direct comparisons and definitive conclusions difficult.

Conclusions:

  • Establishment of a central patient registry is essential for tracking cell-treated individuals.
  • Standardized trial designs and agreed-upon outcome measures are required for robust comparisons.
  • Direct, side-by-side comparisons of different cell types in similar HF patient groups are needed to advance clinical application.